Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE (CDM RX-187463) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 29, 2026 , from http://ppman.hank.ai/transparency/procedure/RX-187463/by-state?code_type=CDM
“VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE (CDM RX-187463) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/RX-187463/by-state?code_type=CDM. Accessed
October 29, 2026 .
“VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE (CDM RX-187463) by State,” HANK Price Transparency ,
accessed October 29, 2026 ,
http://ppman.hank.ai/transparency/procedure/RX-187463/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
RX-187463 — Vutrisiran 25 Mg/0.5 Ml Subcutaneous Syringe
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$292,410
National median
$124,596 – $334,183
IQR (p25 – p75)
4
hospitals filing
1
states
Walking in without insurance?
Cash / self-pay price
Cash median
$156,644
vs. negotiated
-46.4%
Hospitals reporting
4
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for RX-187463 (CDM), with interquartile range
State Median p25 p75
AL $292,410 $124,596 $334,183